Literature DB >> 2215081

Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection.

R E Galinsky1, B L Hoesterey, B D Anderson.   

Abstract

Uptake kinetics of zidovudine into cerebrospinal fluid (CSF) and brain tissue were determined in adult Sprague Dawley male rats after single intravenous injection of 6.7 mg/kg (25 mumol/kg). The drug kinetics in plasma followed biexponential disposition with an initial distribution half-life of approximately 11 minutes and an elimination half-life of 40 minutes. Over the plasma concentration range of 0.2 to 10 micrograms/ml, the cerebrospinal fluid to plasma ratio averaged 14.8 +/- 1.9% whereas the mean brain tissue to plasma ratio was 8.2 +/- 1.2% (uncorrected) or 2.3 +/- 1.8% (corrected) for the brain vascular space contribution. Simultaneous nonlinear regression analysis of brain, CSF and plasma concentration data indicate that the overall rate constant for efflux of drug from brain is approximately 75-fold higher and from CSF is 8-fold higher than the respective rate constants for influx. Thus, the ratio of the efflux to influx appears to be the predominant factor in determining the net accumulation of drug into CSF and brain parenchymal tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215081     DOI: 10.1016/0024-3205(90)90550-b

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  CSF penetration by antiretroviral drugs.

Authors:  Christine Eisfeld; Doris Reichelt; Stefan Evers; Ingo Husstedt
Journal:  CNS Drugs       Date:  2013-01       Impact factor: 5.749

2.  Multifunctional peptide-PEG intercalating conjugates: programmatic of gene delivery to the blood-brain barrier.

Authors:  Hongwei Zhang; Trevor Gerson; Michelle L Varney; Rakesh K Singh; Serguei V Vinogradov
Journal:  Pharm Res       Date:  2010-09-08       Impact factor: 4.200

3.  In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.

Authors:  R Masereeuw; U Jaehde; M W Langemeijer; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

4.  Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.

Authors:  L W Frick; L St John; L C Taylor; G R Painter; P A Furman; D C Liotta; E S Furfine; D J Nelson
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

5.  Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action.

Authors:  E Ljungdahl-Ståhle; E Guzenda; D Böttiger; B Wahren; B Oberg; L Ståhle
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

6.  Comparative brain exposure to (-)-carbovir after (-)-carbovir or (-)-6-aminocarbovir intravenous infusion in rats.

Authors:  Y D Wen; R P Remmel; P T Pham; R Vince; C L Zimmerman
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

Review 7.  Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals.

Authors:  Jacinta Nwamaka Nwogu; Qing Ma; Chinedum Peace Babalola; Waheed Adeola Adedeji; Gene D Morse; Babafemi Taiwo
Journal:  AIDS Res Treat       Date:  2016-09-29

8.  Bile duct ligation enhances AZT CNS toxicity partly by impairing the expression and function of BCRP in rat brain.

Authors:  Yuan-Yuan Qin; Ping Xu; Tong Wu; Chao-Qun Qian; Yi-Lin Fan; Dong-Hao Gen; Liang Zhu; Wei-Min Kong; Han-Yu Yang; Feng Xu; Yi-Ting Yang; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2019-05-29       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.